Společnost PharmTheon s.r.o. zveřejňuje upozornění pro věřitele, zástupce zaměstnanců, zaměstnance a společníky na jejich práva v souvislosti s plánovaným rozdělením společnosti IOCB TECH s.r.o. formou vyčlenění sloučením se společností PharmTheon s.r.o.
Big day for PharmTheon at #BioEquity. We talked about how to bring great science to market - and came to a very Czech conclusion: be brutally honest, don’t fear failure, and keep going. The good news? The great science has always been here. The even better news? We’re building an ecosystem that makes it investable. #PharmTheon #TranslationalResearch #Innovation #CzechScience
🧬 A Day in the Life of a Translational Research Center 🧬 At PharmTheon, no two days are ever the same, but they all share one thing - a drive to turn great science into real-world solutions. We’re a team of 18 scientists - 9 chemists and 9 biologists, working side by side in three bold projects: 1. Overcoming treatment limitations to enhance conventional therapies 2. Advancing innovative molecules to support next-generation immunotherapies 3. Designing optimized molecules for sharper and faster diagnostics What does that look like in real life? Scroll through the stunning behind-the-scenes photos by Jana Plavec, Czech Academy of Sciences. #PharmTheon #IOCBTech #TranslationalResearch #DrugDiscovery #Biotech #Innovation #AppliedResearch #ScienceToImpact #CzechScience